BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioReports
BioInformatics

 
eCommerce Strategies for the Life Science Market
Life science suppliers were among the first companies in any industry to grasp the commercial potential of the Web and some leading companies are now receiving up to 40% of their orders online. Many companies, however, have found that simply launching an electronic catalog and shopping cart are not enough to generate online purchases, so this report probes the technological and organizational challenges associated with eCommerce. Specifically, the report examines the critical elements of a successful eCommerce strategy from developing the optimal mix of relevant content to scientists’ need for easy access to product information, pricing, convenient ordering and technical support.
 
Improving Sales Rep Performance Life Scientists' Perspectives
For this report -- a BioInformatics exclusive -- we polled nearly 1,000 life scientists so that you can equip your sale force with insider knowledge to give them an edge in the increasingly dynamic and competitive life science research market.
 
China's Guidebook for Pharmaceutical Patent Protection
The Chinese social environment for the protection of intellectual property right is complex. The locally produced generics and copy products dominate the Chinese drug market. It is estimated that about 97 percent of the drugs produced by local companies are generics or counterfeits. Facing such complex social environment and market, most overseas and multinational pharmaceutical companies fear that their imported drugs and pharmaceuticals produced in China will be imitated or copied, in turn, their intellectual property will be infringed and benefit will be violated. What reason incurred such fear of overseas and multinational pharmaceutical companies? Why did Eli Lilly & Company fail in its litigation of patent infringement dispute case in China? Why can Pfizer win in an administrative proceeding against the Patent Reexamination Board of the China State Intellectual Property Office (SIPO) for its Viagra patent? Lack of knowledge of the Chinese intellectual property right system and legislation institution, the cultural difference between China and Western countries as well as the language barriers incurred such result.
 
China Pharmaceutical Guidebook Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration A Guidebook of Registration Application for Imported Biological Products
In China, the development of biopharmaceutical industry is later andbehind the developed countries. Just for this reason, the requirements of materials and clinical trials for registration application of biopharmaceuticals stipulated by the Chinese pharmaceutical authority are far from systematic and uniform. The SFDA (State Food and Drug Administration, China) divided the biopharmaceuticals for registration application into two classifications, that is the therapeutic biological products and the prophylactic biological products. However, in the classification of therapeutic biological products, the SFDA does not provide the uniform requirements of materials and clinical trials for application of biological products for the gene therapy, the somatic cell therapy and the allergic therapy, but stipulates the other guidelines for them. These guidelines provide only a common principle for themrespectively because of their diversity and complexity.
 
China Pharmaceutical Guidebook Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration A Guidebook of Registration Application for Imported Chemical Drugs
In China, like in other Western countries, the pharmaceutical authority -- the SFDA -- requests applicant to submit complicate and reliable materials for application of drug registration. The SFDA stipulated the classification of drug registration in order to administer the application of chemical drug registration. At the same time, the SFDA collected the materials for application of chemical drug registration into four categories and 32 items in accordance with various chemical drug categories. When an application of chemical drug registration is filed, the SFDA will request applicant to not only submit designated material items in accordance with prescribed category of chemical drug to apply for registration, but also conduct the clinical trials for certain categorical chemical drugs.
 
Latest Chinese Regulations for Imported Drug Registration A Comprehensive Guidebook for Foreign Pharmaceutical Companies
In China, the process of application and approval for imported drug registration is very complex, because the Chinese pharmaceutical authorities administer and control this process by exorbitant administrative measures and regulations, moreover, these exorbitant administrative regulations are variable and lack of transparency. Therefore, a comprehensive knowledge of the Chinese latest regulations for imported drug registration has been become an essential prerequisite for overseas pharmaceutical manufacturers and producers to achieve a successful application for their products entry into the Chinese drug market.
 
China Pharmaceutical Guidebook Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese pharmaceutical authorities to administer the registration application for such mysterious traditional Chinese medicines? This is the third guidebook of the China Pharmaceutical Guidebook Series. It will provide a detailed introduction of the Chinese pharmaceutical authorities’ requirements for materials and clinical trials of application and approval for imported traditional Chinese medicine. The Chinese pharmaceutical authorities collect the traditional Chinese medicines and the natural medicines into a category for registration application. Therefore, this guidebook will provide not only the introduction for registration application of imported traditional Chinese medicines but for the natural medicines.
 
eMarketing to Life Scientists Amplifying Your Marketing Message
This report examines how life scientists use various e-marketing tools to receive information on the products and/or services related to their research. It also evaluates the effectiveness of these e-marketing tools on a supplier-specific basis.
 
Optimizing Synthetic RNAi - Perspectives from the Pharmaceutical and Biotech Industry
RNA interference (RNAi) has rapidly evolved into a powerful technique to silence gene expression in cells allowing researchers to study the molecular effects of modulating expression at the level of individual genes. The diversity of its applications has made RNAi an indispensable tool for both academic and industrial scientists interested in gene function characterization, signaling pathway analysis, and target validation.
 
Marketing to Life Scientists 2006 - Capitalizing on Media Engagement
Marketing to Life Scientists 2006: Capitalizing on Media Engagement provides insights into the media preferences of life scientists and also identifies suppliers considered to be best-in-class in each of six major marketing media -- print catalogs, Web sites, direct mail, sales representatives, print advertising, and scientific meetings and exhibits. Most importantly, this report identifies a segment of life scientists who are Highly Engaged with the marketing communication of their suppliers and provides strategic insight into marketing to this potentially lucrative group.
 
Market Opportunities in Biodefense Research - Trends and Forecasts
Biodefense research represents one of the fastest growing markets for life science suppliers. Billions of dollars are being invested to support basic research on potential agents of bioterrorism as well as the development of vaccines, diagnostic tests and therapies to detect and counter the effects of a bioterrorist attack. Despite this investment, relatively few tools and techniques are specifically designed for biodefense research, often leaving researchers to adapt products and methodologies currently designed for other uses.
 
The Global Market for Synthetic Oligonucleotides
Oligonucleotides (oligos) represent an important market for life science suppliers because they are an indispensable and ubiquitous tool for scientists working with DNA and/or RNA. As the overall market for oligos is considered mature, suppliers are challenged to distinguish their brand from the many others available to scientists. To help suppliers meet this challenge, we present the opinions of over 700 scientists who use oligos in their research, including what they expect from their oligos and which suppliers they buy from for their different research applications.
 
Customer Loyalty and Satisfaction - Creating a Branded Customer Experience
Customer Loyalty & Satisfaction: Creating a Branded Customer Experience addresses the importance of brand, customer service and product attributes to a customer's level of satisfaction and loyalty. In addition to providing an overview of customer loyalty and satisfaction in the life science market as a whole, this report provides detailed profiles of 24 top suppliers
 
Influencing Brand Preferences in the Flow Cytometry Market
Since the late 1970s, flow cytometry has enabled scientists to analyze a variety of cell types. Today, the applications of this technology are even more broad reaching and powerful. Through optical means, flow cytometers distinguish cells on the basis of size and shape and on the basis of molecules inside and on the surface of cells. Some scientists think about flow cytometry as a “black box”, while others can easily operate the most sophisticated of cytometers. Yet, nearly all scientists appreciate that flow cytometry provides a lot of information about one’s sample in a relatively short period of time. Given that scientists are at various levels of sophistication—and have differing experimental needs when it comes to this versatile technology—how can suppliers best secure and expand their market share?
 
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II
With over 325 commercial suppliers of antibodies, selecting just the right antibody company brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? BioInformatics LLC surveyed nearly 1,000 life scientists worldwide about the types of catalog antibodies that they use and their opinions of commercial suppliers.
 
Maximizing Market Share Through Brand Differentiation
In a crowded life science market, lists of advantages and product features are no longer sufficient to differentiate one company’s offerings from another’s. How does a supplier capture potential customers’ attention and ensure that scientists develop a positive impression of its brand? A strong corporate brand can have a halo effect on a company’s products across market segments, generating excitement and a premium on that company’s goods and services. Brands that can establish an emotional connection with customers benefit from the luxury of “earning” time with scientists to make a rational, persuasive case for buying their products. Without this close bond, however, a corporation’s product brands can get lost in the multitude of companies vying for scientists’ attention.
 
The Market for DNA Molecular Weight Markers: Climbing the Ladder to the top
With nearly one hundred different types of DNA molecular weight markers available from over 20 suppliers, ensuring that one’s products are successful in the market is a challenging endeavor. Given that this product has the potential to produce a constant revenue stream for suppliers because of high profit margins, suppliers must constantly search for ways to ensure that scientists buy their brand DNA molecular weight markers -- and not their competitors' brand.
 
Securing a Competitive Advantage in the Reverse Transcriptase Market
Securing a Competitive Advantage in the Reverse Transcriptase Market provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in this complex and important market.

From a product strategy perspective, reverse transcriptase is critical because it serves as an entry point into a supplier’s profitable kits and reagents (as well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance in such an important market foothold can secure a key competitive advantage for a supplier.

 
The Market for Restriction Enzymes Cutting Out Your Competition
It is difficult to imagine life in the lab today without the benefit of restriction enzymes. Because they are so ubiquitous, these tools have become indispensable to many scientists even at the same time that they are often taken for granted. Nonetheless, restriction enzymes support many quintessential molecular biology applications including cloning, genotyping, mutation analysis and sequencing.
 
Advertising to Life Scientists Maximizing Ad Effectiveness
Even though advertising is a critical and expensive marketing effort, it is estimated that as much as half of all advertising campaigns are ineffective. To help improve the success of your company’s advertising efforts, this report offers insights into ad placement based upon your customers’—the scientists—perspectives.
 
Marketing to Life Scientists Navigating Channels Through Segmentation
Markets are not homogeneous. Life science customers vary on many dimensions and often can be grouped together on one or more characteristics. Suppliers need to identify which of these market segments they can serve effectively. Such decisions require the correct mix of two important elements: insight into consumer behavior and careful strategic planning. In the seventh edition of our best-selling report, Marketing to Life Scientists, we conducted an in-depth examination of the opinions and preferences of life science customers.
 
The Taq Wars Competitive Intelligence on How to Survive
As the engine that fuels the polymerase chain reaction (PCR), one of the most important inventions in molecular biology, Taq polymerase has transformed how life science research is conducted. This powerful technique for DNA amplification relies on the amazing processivity of DNA polymerase I enzymes from the bacterium, Thermus aquaticus (Taq polymerase). Because many of its enzymes—including Taq polymerase—are thermostable, it thrives in blistering hot environments. The thermostability of Taq polymerase is the critical feature that facilitated the development of PCR and insured its commercial success.
 
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.



BioPortfolio's BioReports catalogue is one of the most comprehensive sources of specialized life science management reports on the internet. You can search our database by using the links below:

If you represent a publisher who wishes to market via BioPortfolio's BioReports service please contact Peter Barfoot.
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.